Global Artificial Organs & Bionic Implants Market Insights and Forecast to 2027

Artificial organs and bionics are man-made devices that can be implanted or integrated into humans to either replace a natural organ or provide support for the purpose of restoring a specific function or a group of related functions so that the patient may return to normal life as soon as possible.
North America accounted for the largest share of the global artificial organs & bionic implants market and is expected to maintain its position in the coming years as well.

Market Analysis and Insights: Global Artificial Organs & Bionic Implants Market
The global Artificial Organs & Bionic Implants market is valued at US$ 48990 million in 2019. The market size will reach US$ 76270 million by the end of 2026, growing at a CAGR of 6.5% during 2021-2026.

Global Artificial Organs & Bionic Implants Scope and Market Size
Artificial Organs & Bionic Implants market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Organs & Bionic Implants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Others

Segment by Application
Hospitals
Clinical Research Institutions
Others

By Company
Medtronic
Boston Scientific
Roche
Zimmer Biomet
Asahi Kasei Medical
Baxter International
Abiomed
Berlin Heart
Thoratec
Gambro AB
Jarvik Heart

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions